National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Vulvar Cancer Treatment (PDQ®)
Patient Version   Health Professional Version   En español   Last Modified: 05/22/2008



Purpose of This PDQ Summary






General Information






Cellular Classification






Stage Information






Treatment Option Overview






Stage 0 Vulvar Cancer






Stage I Vulvar Cancer






Stage II Vulvar Cancer






Stage III Vulvar Cancer






Stage IV Vulvar Cancer






Recurrent Vulvar Cancer






Get More Information From NCI






Changes to This Summary (05/22/2008)






More Information



Page Options
Print This Page
Print Entire Document
View Entire Document
E-Mail This Document
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
Quit Smoking Today
NCI Highlights
The Nation's Investment in Cancer Research FY 2010

Report to Nation Finds Declines in Cancer Incidence, Death Rates

High Dose Chemotherapy Prolongs Survival for Leukemia

Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E
Cellular Classification

Presented below is an adaptation of the histologic classification of vulvar disease and precursor lesions of cancer of the vulva developed by the International Society for the Study of Vulvar Disease.

Non-neoplastic epithelial disorders of skin and mucosa

  • Lichen sclerosus (lichen sclerosus et atrophicus).
  • Squamous cell hyperplasia (formerly hyperplastic dystrophy).
  • Other dermatoses.

Classification of vulvar intraepithelial neoplasia (VIN)

  1. Mild dysplasia (formerly mild atypia).
  2. Moderate dysplasia (formerly moderate atypia).
  3. Severe dysplasia (formerly severe atypia).
  4. Carcinoma in situ.

Paget disease of the vulva

  • Characteristic large pale cells in epithelium and skin adnexa.

Other histologies

  • Basal cell carcinoma.
  • Verrucous carcinoma.
  • Sarcoma.
  • Histiocytosis X.
  • Malignant melanoma.

Back to Top

< Previous Section  |  Next Section >


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov